Suchergebnisse - Angela Panoskaltsis‐Mortari
- Treffer 1 - 20 von 100
- Zur nächsten Seite
-
1
3D bioprinting for lungs and hollow organs von Zachary Galliger, Caleb Vogt, Angela Panoskaltsis‐Mortari
Veröffentlicht 2019Revisão -
2
Leukocyte migration and graft-versus-host disease von Christian Wysocki, Angela Panoskaltsis‐Mortari, Bruce R. Blazar, Jonathan S. Serody
Veröffentlicht 2005Revisão -
3
Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility co... von BR Blazar, PA Taylor, Angela Panoskaltsis‐Mortari, GS Gray, DA Vallera
Veröffentlicht 1995Artigo -
4
-
5
-
6
Rapamycin Inhibits the Generation of Graft-Versus-Host Disease- and Graft-Versus-Leukemia-Causing T Cells by Interfering with the Production of Th1 or Th1 Cytotoxic Cytokines von Bruce R. Blazar, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, Daniel A. Vallera
Veröffentlicht 1998Artigo -
7
A New Murine Model for Bronchiolitis Obliterans Post–Bone Marrow Transplant von Angela Panoskaltsis‐Mortari, Kevin Tram, Andrew Price, Christine Wendt, Bruce R. Blazar
Veröffentlicht 2007Artigo -
8
-
9
-
10
-
11
Stem Cells and Cell Therapies in Lung Biology and Lung Diseases von Daniel J. Weiss, Jay K. Kolls, Luis A. Ortiz, Angela Panoskaltsis‐Mortari, Darwin J. Prockop
Veröffentlicht 2008Artigo -
12
In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations von Michael Carlson, Michelle L. West, James M. Coghill, Angela Panoskaltsis‐Mortari, Bruce R. Blazar, Jonathan S. Serody
Veröffentlicht 2008Artigo -
13
Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients von Bruce R. Blazar, Byoung S. Kwon, Angela Panoskaltsis‐Mortari, Kyu B. Kwak, Jacques J. Peschon, Patricia A. Taylor
Veröffentlicht 2001Artigo -
14
In vivo imaging of graft-versus-host-disease in mice von Angela Panoskaltsis‐Mortari, Andrew Price, John R. Hermanson, Elizabeth Taras, Chris Lees, Jonathan S. Serody, Bruce R. Blazar
Veröffentlicht 2004Artigo -
15
-
16
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality von Lisa K. Jasperson, Christoph Bucher, Angela Panoskaltsis‐Mortari, Andrew L. Mellor, David H. Munn, Bruce R. Blazar
Veröffentlicht 2009Artigo -
17
CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or... von Bruce R. Blazar, Patricia A. Taylor, Michael W. Boyer, Angela Panoskaltsis‐Mortari, James P. Allison, Daniel A. Vallera
Veröffentlicht 1997Artigo -
18
-
19
Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. von Bruce R. Blazar, Arlene H. Sharpe, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, G S Gray, Robert Korngold, Daniel A. Vallera
Veröffentlicht 1996Artigo -
20
Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients von Patricia A. Taylor, Michael Ehrhardt, Matthew M. Roforth, Jessica M. Swedin, Angela Panoskaltsis‐Mortari, Jonathan S. Serody, Bruce R. Blazar
Veröffentlicht 2006Artigo
Suchwerkzeuge:
Ähnliche Schlagworte
Immunology
Biology
Medicine
Internal medicine
Immune system
Graft-versus-host disease
Cancer research
Biochemistry
T cell
Cell biology
Transplantation
In vitro
Stem cell
Genetics
Cytotoxic T cell
Pathology
Receptor
Disease
CD8
Bone marrow
Lung
Antibody
Antigen
Chemistry
Leukemia
Cytokine
Gene
Chemotherapy
Inflammation
Adoptive cell transfer